Hospira, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

HSP 89.96
price chart
Pfizer Inc. Closes Hospira, Inc. Acquisition; Can It Trigger A Split?
Pfizer Inc. (NYSE:PFE) on Thursday closed acquisition of injectable drug-maker, Hospira Inc., for $17 billion. Hospira is now no longer listed on the New York Stock Exchange; the company's shares stopped trading at market close.
Pfizer Inc. Commences Exchange Offers for Hospira Notes  Business Wire (press release)
Pfizer Inc. completes acquisition of Hospira  The Hindu
Pfizer Inc. To Complete Hospira, Inc. Acquisition Next Month
Pfizer Inc. (NYSE:PFE) recently announced that U.S. regulators have approved its $16 billion acquisition deal for Hospira Inc. (NYSE:HSP) to be closed by next month. However, the approval was contingent on the divesture of some of Pfizer's assets.
Pfizer Gets Approval For Hospira Acquisition  24/7 Wall St.
Pfizer Gets US Approval to Acquire Hospira  Wall Street Journal
Hospira Acquisition To Add Shareholder Value For Pfizer
The acquisition of Hospira will bring a new set of generic product offerings to Pfizer. The new products will add revenue immediately, creating incremental shareholder value in the current quarter and significant shareholder value over the long term ...
Cubist Pharmaceuticals, Inc. v. Hospira, Inc., Inc., Nos. 2015-1197, 2015-1204 ...
In Cubist Pharmaceuticals, Inc. v. Hospira, Inc., the Federal Circuit Court of Appeals affirmed the United States District Court for the District of Delaware's holding that four of five follow-on patents regarding the dosage and purity requirements of ...
CCI approves merger of Pfizer, Hospira, Inc. and Perkins Holding Company
CCI by its order dated June 11, 2015 approved the execution of an Agreement and Plan of Merger between Pfizer, Hospira, Inc. (Hospira) and Perkins Holding Company (Perkins), a wholly owned subsidiary of Pfizer. The proposed combination relates to the ...
FDA warns of security flaw in Hospira infusion pumps
BOSTON The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take remote control of the system.
FDA says hospitals should stop using Hospira pump  Los Angeles Times
Fed. Circ. Affirms Hospira Win In Generic Cubicin Patent Suit
Law360, New York (November 12, 2015, 7:34 PM ET) -- The Federal Circuit on Thursday upheld a trial court's decision that four of five patents Merck & Co.
Merck's Cubist Loses Bid to Block Generic Cubicin Past 2016  Bloomberg
US Court invalidates four of five Merck patents on Cubicin  The Pharma Letter (registration)
Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira Deal
Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year's purchase of Hospira Inc., people with knowledge of the matter said.
Hospira Inc (HSP) q1 2015 Sentiment
Hospira Inc (HSP) hedge funds sentiment decreased to 0.85 in q1 2015. Its down -0.22, from 1.07 in 2014Q4. The sentiment turned negative, as 200 active investment managers opened new and increased holdings, while 236 sold and decreased their stock ...
Hospira Recalls One Lot of Magnesium Sulfate for Injection
Hospira, Inc has issued a voluntary recall of one lot of magnesium sulfate in water for injection (0.325 mEq Mg**/mL) after a customer report of an incorrect barcode on the primary bag labeling, the company has announced.
Hospira Recalls One Lot of Magnesium Sulfate  Pharmaceutical Technology Magazine (press release) (blog)
Seizure Drug Recalled Due To Potentially Incorrect Barcode  Monthly Prescribing Reference (registration)